In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer

BACKGROUND: Endometrial cancer is the most common cancer of the female reproductive tract. Based on our previous studies we speculated that miR-92a exhibited pro-oncogenic properties in endometrial cancer, and therefore its inhibition could be used as a therapeutic measure in this disease. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Torres, Anna, Kozak, Joanna, Korolczuk, Agnieszka, Wdowiak, Paulina, Domańska-Glonek, Ewa, Maciejewski, Ryszard, Torres, Kamil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080781/
https://www.ncbi.nlm.nih.gov/pubmed/27782822
http://dx.doi.org/10.1186/s12885-016-2867-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080781/
https://www.ncbi.nlm.nih.gov/pubmed/27782822
http://dx.doi.org/10.1186/s12885-016-2867-z

Ejemplares similares